Aveir™ VR Leadless Pacemaker is able to be implanted with an easy-to-use introducer that accesses the heart through the femoral vein access.
This video shows the process for Aveir VR LP’s ability to map prior to fixation which allows doctors and clinics to ensure the LP is optimally placed before affixing the device to the heart with Aveir VR LP’s helix fixation mechanism.
Aveir VR LP is also designed for chronic retrieval through a similar process with minimized damage to the heart.
Furthermore Aveir VR LP is designed to be expanded to a dual chamber system.*
For more information: [ Ссылка ]
To view important safety information visit: [ Ссылка ]
™ Indicates a trademark of the Abbott group of companies
*The LP device electronics are designed to be enabled by future software, upon regulatory approval, to support dual chamber pacing in the future. Dual chamber pacing system is currently in clinical trial (Clinicaltrials.gov NCT #05252702) and limited to investigational use only.
MAT- 2213533 v1.0 | Item approved for U.S. use only
